Skip to main content
. 2017 Apr 27;2(1):e000168. doi: 10.1136/esmoopen-2017-000168

Table 2.

All grade adverse events in both arms. Only the worst grade toxicity is shown

Variable Pemetrexed arm (n=141) Gefitinib arm (n=145)
Haematological
Anaemia 111 (78.7%)  77 (53.1%)
Neutropaenia  53 (37.6%)  4 (2.8%)
Thrombocytopaenia  57 (40.4%)  10 (6.9%)
Biochemical
Raised SGOT  57 (40.4%)  77 (53.1%)
Raised SGPT  72 (51.1%)  79 (54.5%)
Clinical
Skin rash  40 (28.4%) 101 (69.7%)
Loose motions  39 (27.7%)  67 (46.2%)
Vomiting  34 (24.1%)  19 (13.1%)
Febrile neutropaenia  12 (8.5%)   1 (0.7%)

SGOT, serum glutamic oxaloacetic transaminase; SGPT, serum glutamic aspartate aminotransferase.